-
Plans to vaccinate Americans against COVID-19 had a big setback Tuesday. Federal officials called for a pause in administering Johnson & Johnson’s vaccine, to look into reports that it caused blood clots. And that news reverberated at clinics where the vaccine had already been used.
-
Kent State University and the University of Akron are among schools calling off J&J shot clinics; House Republicans have proposed a 2% personal income tax cut in their version of the state budget, and other stories.
-
Distribution of the manufacturer's shots come to a halt as the CDC and FDA investigate cases of blood clots in six women.
-
Ohio Gov. Mike DeWine and health officials from across the state urged Ohioans Tuesday to continue signing up for Pfizer and Moderna COVID-19 vaccine appointments, following a recommendation by federal agencies to temporarily pause administration of the Johnson & Johnson shot.
-
Gov. Mike DeWine and the Ohio Department of Health are advising all COVID-19 vaccine providers to temporarily pause the use of the Johnson and Johnson vaccine as federal officials review six "extremely rare" cases of severe blood clotting. The U.S. has administered 6.8 million doses of the Johnson and Johnson vaccine.
-
Spots at the fairgrounds vaccination site rapidly fill due to demand in the area.
-
Gov. Mike DeWine says, beginning next week, Ohio’s colleges and universities will have the opportunity to hold vaccine clinics for their students.
-
The state is opening up eligibility in Phase 1C so that those 60 and older and people in certain occupations can be vaccinated.
-
The new shots will be shipped to local health departments, hospitals and pharmacies.
-
Shortages and problems with distribution are affecting the rollout.